Begin main content

Call for Feedback: Early Identification of Stroke

January 17, 2020
A new project on Early Identification of Stroke is now available for feedback from all interested stakeholders. Early Identification of Stroke Call for Feedback: 2020-01-17 Feedback Due By: 2020-01-31 Consultation Document: Horizon Scanning Report Product Type: Issues in Emerging Health Technologies Submit Feedback

New at CADTH — January 2020

January 10, 2020
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.

CADTH Pharmaceutical Reviews Update — Issue 12

January 9, 2020
See Pharmaceutical Reviews Update – Issue 12 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: A new process for the submission and review of cell and gene therapies Updated guidelines on fees for CADTH pharmaceutical reviews Pending updates to the category 1 r...

Patient Input and Clinical Experts: Vonvendi

January 2, 2020
CADTH has received the following notice(s) of pending drug submission(s). Brand name Vonvendi Generic name von Willebrand Factor [recombinant] Manufacturer Shire Pharma Canada ULC, now part of Takeda Indication(s) von Willebrand disease, adults, treatment and perioperative management Proj...

Drug Reimbursement Recommendation - inotersen (Tegsedi)

December 20, 2019
Today, CADTH has issued final recommendations for: inotersen (Tegsedi) Indications: hereditary transthyretin amyloidosis Recommendation: Reimburse with clinical criteria and/or conditions For more information